Winslow Evans & Crocker’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-98
Closed -$7.86K 1310
2016
Q4
$7.86K Hold
98
﹤0.01% 936
2016
Q3
$7.82K Hold
98
﹤0.01% 964
2016
Q2
$7.64K Hold
98
﹤0.01% 945
2016
Q1
$5.39K Hold
98
﹤0.01% 1014
2015
Q4
$6.06K Hold
98
﹤0.01% 1019
2015
Q3
$6.19K Hold
98
﹤0.01% 985
2015
Q2
$7.16K Sell
98
-50
-34% -$3.61K ﹤0.01% 1005
2015
Q1
$9.62K Hold
148
﹤0.01% 887
2014
Q4
$9.56K Hold
148
﹤0.01% 891
2014
Q3
$8.84K Buy
148
+1
+0.7% +$65 ﹤0.01% 917
2014
Q2
$10.2K Hold
147
﹤0.01% 845
2014
Q1
$9.61K Hold
147
﹤0.01% 855
2013
Q4
$9K Buy
+147
New +$8.51K ﹤0.01% 967

Other funds holding STJ

Winslow Evans & Crocker's STJ Position: Q1 2017 in Review

Winslow Evans & Crocker sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 98 shares — an estimated $7.86K sold.

Winslow Evans & Crocker first reported a position in STJ in Q4 2013 and held it in 13 quarters. The position peaked at $10.2K in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Winslow Evans & Crocker reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Winslow Evans & Crocker sold 98 St Jude Medical shares in Q1 2017, an estimated $7.86K.
  • Winslow Evans & Crocker first reported a position in St Jude Medical in Q4 2013 and held it in 13 quarters.
  • Winslow Evans & Crocker's St Jude Medical position peaked at $10.2K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Winslow Evans & Crocker's 13F filing for Q1 2017, filed 14 Apr 2017.